BBP

Virtus LifeSci Biotech Products …

• Benzinga·03/26 14:04

  ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check

• Benzinga·03/17 17:54

  ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use

• Benzinga·03/13 14:44

  Why Is ImmunityBio Stock Soaring On Friday?

• Benzinga·03/09 15:03

  ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug

• Benzinga·02/17 14:44

  Why Is ImmunityBio Stock Gaining Tuesday?

• Seeking Alpha·01/22 16:12

  Moderna’s rally ripples through biotech and health care ETFs

• Seeking Alpha·01/22 11:07

  Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?

• Seeking Alpha·01/08 10:30

  Healthcare Stocks In Focus: Assessing The Outlook For 2026

• Seeking Alpha·11/27/2025 23:55

  Health Care's Epic Rally

• Seeking Alpha·11/11/2025 15:13

  Investing In Health Stocks - How Policy Clarity Is Opening Doors

• Seeking Alpha·11/01/2025 07:00

  Introducing Charting Disruption: Outlook For 2026 And Beyond

• NASDAQ·10/30/2025 13:00

  Biotech ETFs Hovering Around a 52-Week: Here's Why

• NASDAQ·10/20/2025 10:00

  Biotech ETFs Bounce Back in 2025: Here's Why

• Seeking Alpha·10/10/2025 10:30

  Checking The Pulse Of The Healthcare Sector

• Seeking Alpha·10/07/2025 16:05

  Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers